Blockade of adenosine A2A receptors reverses early spatial memory defects in the APP/PS1 mouse model of Alzheimer’s disease by promoting synaptic plasticity of adult-born granule cells. Here, ADORA2A is linked to early-onset autosomal dominant Alzheimer disease.